ArticleViruses2022

Evaluation of Rapid Lateral-Flow Tests Directed against the SARS-CoV-2 Nucleoprotein Using Viral Suspensions Belonging to Different Lineages of SARS-CoV-2.

Sylvie Pillet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.